A2M |
139 |
alpha-2-macroglobulin |
|
5 |
3 |
ABL1 |
78 |
ABL proto-oncogene 1, non-receptor tyrosine kinase |
|
5 |
7 |
ADCY5 |
255 |
adenylate cyclase 5 |
|
1 |
1 |
AGPAT2 |
187 |
1-acylglycerol-3-phosphate O-acyltransferase 2 |
|
3 |
0 |
AGTR1 |
264 |
angiotensin II receptor, type 1 |
|
5 |
1 |
AIFM1 |
135 |
apoptosis-inducing factor, mitochondrion-associated, 1 |
|
4 |
1 |
AKT1 |
35 |
v-akt murine thymoma viral oncogene homolog 1 |
|
45 |
13 |
APEX1 |
195 |
APEX nuclease (multifunctional DNA repair enzyme) 1 |
|
11 |
8 |
APOC3 |
102 |
apolipoprotein C-III |
|
7 |
0 |
APOE |
138 |
apolipoprotein E |
|
28 |
3 |
APP |
137 |
amyloid beta (A4) precursor protein |
|
35 |
4 |
APTX |
95 |
aprataxin |
|
6 |
3 |
AR |
110 |
androgen receptor |
|
8 |
20 |
ARHGAP1 |
249 |
Rho GTPase activating protein 1 |
|
1 |
1 |
ARNTL |
251 |
aryl hydrocarbon receptor nuclear translocator-like |
|
11 |
3 |
ATF2 |
193 |
activating transcription factor 2 |
|
10 |
10 |
ATM |
9 |
ATM serine/threonine kinase |
|
42 |
12 |
ATP5O |
146 |
ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit |
|
3 |
0 |
ATR |
231 |
ATR serine/threonine kinase |
|
7 |
4 |
BAK1 |
278 |
BCL2-antagonist/killer 1 |
|
3 |
4 |
BAX |
119 |
BCL2-associated X protein |
|
21 |
3 |
BCL2 |
69 |
B-cell CLL/lymphoma 2 |
|
30 |
7 |
BDNF |
191 |
brain-derived neurotrophic factor |
|
27 |
1 |
BLM |
68 |
Bloom syndrome, RecQ helicase-like |
|
15 |
8 |
BMI1 |
188 |
BMI1 proto-oncogene, polycomb ring finger |
|
13 |
0 |
BRCA1 |
61 |
breast cancer 1, early onset |
|
21 |
28 |
BRCA2 |
79 |
breast cancer 2, early onset |
|
8 |
4 |
BSCL2 |
186 |
Berardinelli-Seip congenital lipodystrophy 2 (seipin) |
|
3 |
0 |
BUB1B |
197 |
BUB1 mitotic checkpoint serine/threonine kinase B |
|
10 |
3 |
BUB3 |
240 |
BUB3 mitotic checkpoint protein |
|
4 |
1 |
C1QA |
287 |
complement component 1, q subcomponent, A chain |
|
1 |
0 |
CACNA1A |
133 |
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
|
7 |
0 |
CAT |
107 |
catalase |
|
37 |
1 |
CCNA2 |
177 |
cyclin A2 |
|
3 |
7 |
CDC42 |
250 |
cell division cycle 42 |
|
2 |
3 |
CDK1 |
201 |
cyclin-dependent kinase 1 |
|
4 |
5 |
CDK7 |
299 |
cyclin-dependent kinase 7 |
|
0 |
0 |
CDKN1A |
284 |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
|
7 |
3 |
CDKN2A |
226 |
cyclin-dependent kinase inhibitor 2A |
|
35 |
1 |
CDKN2B |
288 |
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
|
2 |
0 |
CEBPA |
88 |
CCAAT/enhancer binding protein (C/EBP), alpha |
|
14 |
7 |
CEBPB |
89 |
CCAAT/enhancer binding protein (C/EBP), beta |
|
9 |
16 |
CETP |
262 |
cholesteryl ester transfer protein, plasma |
|
7 |
0 |
CHEK2 |
247 |
checkpoint kinase 2 |
|
8 |
6 |
CISD2 |
265 |
CDGSH iron sulfur domain 2 |
|
2 |
0 |
CLOCK |
252 |
clock circadian regulator |
|
17 |
1 |
CLU |
220 |
clusterin |
|
16 |
6 |
CNR1 |
282 |
cannabinoid receptor 1 (brain) |
|
4 |
0 |
COQ7 |
132 |
coenzyme Q7 homolog, ubiquinone (yeast) |
|
11 |
0 |
CREB1 |
192 |
cAMP responsive element binding protein 1 |
|
15 |
5 |
CREBBP |
64 |
CREB binding protein |
|
11 |
19 |
CSNK1E |
244 |
casein kinase 1, epsilon |
|
7 |
0 |
CTF1 |
304 |
cardiotrophin 1 |
|
0 |
2 |
CTGF |
206 |
connective tissue growth factor |
|
3 |
2 |
CTNNB1 |
223 |
catenin (cadherin-associated protein), beta 1, 88kDa |
|
16 |
9 |
DBN1 |
228 |
drebrin 1 |
|
4 |
0 |
DDIT3 |
203 |
DNA-damage-inducible transcript 3 |
|
4 |
4 |
DGAT1 |
291 |
diacylglycerol O-acyltransferase 1 |
|
0 |
0 |
DLL3 |
225 |
delta-like 3 (Drosophila) |
|
12 |
0 |
E2F1 |
18 |
E2F transcription factor 1 |
|
14 |
8 |
EEF1A1 |
189 |
eukaryotic translation elongation factor 1 alpha 1 |
|
5 |
1 |
EEF1E1 |
266 |
eukaryotic translation elongation factor 1 epsilon 1 |
|
3 |
0 |
EEF2 |
103 |
eukaryotic translation elongation factor 2 |
|
5 |
1 |
EFEMP1 |
260 |
EGF containing fibulin-like extracellular matrix protein 1 |
|
3 |
0 |
EGF |
48 |
epidermal growth factor |
|
15 |
6 |
EGFR |
40 |
epidermal growth factor receptor |
|
13 |
17 |
EGR1 |
76 |
early growth response 1 |
|
5 |
4 |
EIF5A2 |
289 |
eukaryotic translation initiation factor 5A2 |
|
0 |
0 |
ELN |
230 |
elastin |
|
9 |
0 |
EMD |
121 |
emerin |
|
4 |
1 |
EP300 |
94 |
E1A binding protein p300 |
|
11 |
21 |
EPOR |
52 |
erythropoietin receptor |
|
5 |
6 |
EPS8 |
267 |
epidermal growth factor receptor pathway substrate 8 |
|
5 |
1 |
ERBB2 |
41 |
erb-b2 receptor tyrosine kinase 2 |
|
9 |
10 |
ERCC1 |
149 |
excision repair cross-complementation group 1 |
|
13 |
2 |
ERCC2 |
11 |
excision repair cross-complementation group 2 |
|
19 |
5 |
ERCC3 |
104 |
excision repair cross-complementation group 3 |
|
10 |
4 |
ERCC4 |
261 |
excision repair cross-complementation group 4 |
|
7 |
2 |
ERCC5 |
109 |
excision repair cross-complementation group 5 |
|
5 |
4 |
ERCC6 |
92 |
excision repair cross-complementation group 6 |
|
16 |
5 |
ERCC8 |
12 |
excision repair cross-complementation group 8 |
|
10 |
2 |
ESR1 |
216 |
estrogen receptor 1 |
|
23 |
15 |
FAS |
115 |
Fas cell surface death receptor |
|
26 |
1 |
FEN1 |
114 |
flap structure-specific endonuclease 1 |
|
10 |
4 |
FGF21 |
293 |
fibroblast growth factor 21 |
|
0 |
0 |
FGF23 |
259 |
fibroblast growth factor 23 |
|
8 |
0 |
FGFR1 |
169 |
fibroblast growth factor receptor 1 |
|
8 |
2 |
FLT1 |
171 |
fms-related tyrosine kinase 1 |
|
3 |
3 |
FOS |
50 |
FBJ murine osteosarcoma viral oncogene homolog |
|
19 |
9 |
FOXM1 |
131 |
forkhead box M1 |
|
21 |
1 |
FOXO1 |
124 |
forkhead box O1 |
|
43 |
6 |
FOXO3 |
123 |
forkhead box O3 |
|
56 |
2 |
FOXO4 |
183 |
forkhead box O4 |
|
19 |
3 |
GCLC |
237 |
glutamate-cysteine ligase, catalytic subunit |
|
7 |
1 |
GCLM |
238 |
glutamate-cysteine ligase, modifier subunit |
|
6 |
1 |
GH1 |
26 |
growth hormone 1 |
|
66 |
1 |
GHR |
1 |
growth hormone receptor |
|
32 |
12 |
GHRH |
2 |
growth hormone releasing hormone |
|
14 |
3 |
GHRHR |
222 |
growth hormone releasing hormone receptor |
|
16 |
1 |
GPX1 |
153 |
glutathione peroxidase 1 |
|
27 |
1 |
GPX4 |
257 |
glutathione peroxidase 4 |
|
2 |
0 |
GRB2 |
122 |
growth factor receptor-bound protein 2 |
|
7 |
23 |
GRN |
300 |
granulin |
|
0 |
0 |
GSK3A |
295 |
glycogen synthase kinase 3 alpha |
|
0 |
0 |
GSK3B |
97 |
glycogen synthase kinase 3 beta |
|
7 |
5 |
GSR |
154 |
glutathione reductase |
|
12 |
0 |
GSS |
155 |
glutathione synthetase |
|
6 |
0 |
GSTA4 |
156 |
glutathione S-transferase alpha 4 |
|
8 |
0 |
GSTP1 |
157 |
glutathione S-transferase pi 1 |
|
13 |
1 |
GTF2H2 |
111 |
general transcription factor IIH, polypeptide 2, 44kDa |
|
3 |
3 |
H2AFX |
212 |
H2A histone family, member X |
|
12 |
5 |
HBP1 |
196 |
HMG-box transcription factor 1 |
|
5 |
4 |
HDAC1 |
151 |
histone deacetylase 1 |
|
11 |
19 |
HDAC2 |
207 |
histone deacetylase 2 |
|
7 |
7 |
HDAC3 |
25 |
histone deacetylase 3 |
|
7 |
7 |
HELLS |
101 |
helicase, lymphoid-specific |
|
6 |
0 |
HESX1 |
184 |
HESX homeobox 1 |
|
4 |
2 |
HIC1 |
253 |
hypermethylated in cancer 1 |
|
2 |
1 |
HIF1A |
65 |
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
17 |
6 |
HMGB1 |
176 |
high mobility group box 1 |
|
9 |
12 |
HMGB2 |
178 |
high mobility group box 2 |
|
5 |
3 |
HOXB7 |
213 |
homeobox B7 |
|
5 |
2 |
HOXC4 |
214 |
homeobox C4 |
|
4 |
2 |
HRAS |
38 |
Harvey rat sarcoma viral oncogene homolog |
|
21 |
7 |
HSF1 |
125 |
heat shock transcription factor 1 |
|
23 |
10 |
HSP90AA1 |
74 |
heat shock protein 90kDa alpha (cytosolic), class A member 1 |
|
10 |
15 |
HSPA1A |
160 |
heat shock 70kDa protein 1A |
|
31 |
11 |
HSPA1B |
161 |
heat shock 70kDa protein 1B |
|
4 |
0 |
HSPA8 |
199 |
heat shock 70kDa protein 8 |
|
12 |
6 |
HSPA9 |
152 |
heat shock 70kDa protein 9 (mortalin) |
|
4 |
2 |
HSPD1 |
159 |
heat shock 60kDa protein 1 (chaperonin) |
|
6 |
2 |
HTRA2 |
294 |
HtrA serine peptidase 2 |
|
0 |
0 |
HTT |
98 |
huntingtin |
|
17 |
6 |
IGF1 |
28 |
insulin-like growth factor 1 (somatomedin C) |
|
118 |
2 |
IGF1R |
15 |
insulin-like growth factor 1 receptor |
|
36 |
12 |
IGF2 |
29 |
insulin-like growth factor 2 |
|
21 |
2 |
IGFBP2 |
279 |
insulin-like growth factor binding protein 2, 36kDa |
|
1 |
0 |
IGFBP3 |
73 |
insulin-like growth factor binding protein 3 |
|
10 |
2 |
IKBKB |
297 |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta |
|
0 |
1 |
IL2 |
46 |
interleukin 2 |
|
7 |
2 |
IL2RG |
49 |
interleukin 2 receptor, gamma |
|
2 |
4 |
IL6 |
144 |
interleukin 6 |
|
23 |
2 |
IL7 |
167 |
interleukin 7 |
|
6 |
2 |
IL7R |
27 |
interleukin 7 receptor |
|
5 |
6 |
INS |
30 |
insulin |
|
77 |
5 |
INSR |
42 |
insulin receptor |
|
33 |
11 |
IRS1 |
32 |
insulin receptor substrate 1 |
|
21 |
9 |
IRS2 |
34 |
insulin receptor substrate 2 |
|
16 |
10 |
JAK2 |
215 |
Janus kinase 2 |
|
9 |
13 |
JUN |
172 |
jun proto-oncogene |
|
22 |
23 |
JUND |
45 |
jun D proto-oncogene |
|
7 |
7 |
KCNA3 |
268 |
potassium channel, voltage gated shaker related subfamily A, member 3 |
|
6 |
1 |
KL |
17 |
klotho |
|
33 |
0 |
LEP |
217 |
leptin |
|
36 |
3 |
LEPR |
218 |
leptin receptor |
|
14 |
4 |
LMNA |
14 |
lamin A/C |
|
61 |
4 |
LMNB1 |
181 |
lamin B1 |
|
5 |
4 |
LRP2 |
134 |
low density lipoprotein receptor-related protein 2 |
|
2 |
4 |
MAP3K5 |
179 |
mitogen-activated protein kinase kinase kinase 5 |
|
4 |
5 |
MAPK14 |
168 |
mitogen-activated protein kinase 14 |
|
28 |
7 |
MAPK3 |
175 |
mitogen-activated protein kinase 3 |
|
12 |
4 |
MAPK8 |
163 |
mitogen-activated protein kinase 8 |
|
26 |
11 |
MAPK9 |
174 |
mitogen-activated protein kinase 9 |
|
16 |
6 |
MAPT |
205 |
microtubule-associated protein tau |
|
35 |
5 |
MAX |
208 |
MYC associated factor X |
|
5 |
4 |
MDM2 |
210 |
MDM2 proto-oncogene, E3 ubiquitin protein ligase |
|
9 |
12 |
MED1 |
173 |
mediator complex subunit 1 |
|
2 |
5 |
MIF |
290 |
macrophage migration inhibitory factor (glycosylation-inhibiting factor) |
|
0 |
0 |
MLH1 |
243 |
mutL homolog 1 |
|
5 |
4 |
MSRA |
127 |
methionine sulfoxide reductase A |
|
11 |
0 |
MT-CO1 |
158 |
mitochondrially encoded cytochrome c oxidase I |
|
5 |
0 |
MT1E |
292 |
metallothionein 1E |
|
0 |
0 |
MTOR |
221 |
mechanistic target of rapamycin (serine/threonine kinase) |
|
26 |
1 |
MXD1 |
209 |
MAX dimerization protein 1 |
|
2 |
5 |
MXI1 |
90 |
MAX interactor 1, dimerization protein |
|
3 |
2 |
MYC |
39 |
v-myc avian myelocytomatosis viral oncogene homolog |
|
22 |
12 |
NBN |
44 |
nibrin |
|
22 |
9 |
NCOR1 |
43 |
nuclear receptor corepressor 1 |
|
6 |
9 |
NCOR2 |
276 |
nuclear receptor corepressor 2 |
|
1 |
8 |
NFE2L1 |
307 |
nuclear factor, erythroid 2-like 1 |
|
0 |
2 |
NFE2L2 |
283 |
nuclear factor, erythroid 2-like 2 |
|
7 |
2 |
NFKB1 |
82 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
25 |
11 |
NFKB2 |
20 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) |
|
24 |
3 |
NFKBIA |
219 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
9 |
5 |
NGF |
31 |
nerve growth factor (beta polypeptide) |
|
13 |
2 |
NGFR |
37 |
nerve growth factor receptor |
|
5 |
2 |
NOG |
229 |
noggin |
|
7 |
0 |
NR3C1 |
75 |
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
|
14 |
23 |
NRG1 |
24 |
neuregulin 1 |
|
6 |
3 |
NUDT1 |
296 |
nudix (nucleoside diphosphate linked moiety X)-type motif 1 |
|
0 |
0 |
PAPPA |
254 |
pregnancy-associated plasma protein A, pappalysin 1 |
|
8 |
0 |
PARP1 |
60 |
poly (ADP-ribose) polymerase 1 |
|
39 |
7 |
PCK1 |
248 |
phosphoenolpyruvate carboxykinase 1 (soluble) |
|
2 |
0 |
PCMT1 |
162 |
protein-L-isoaspartate (D-aspartate) O-methyltransferase |
|
5 |
0 |
PCNA |
113 |
proliferating cell nuclear antigen |
|
12 |
20 |
PDGFB |
47 |
platelet-derived growth factor beta polypeptide |
|
7 |
3 |
PDGFRA |
285 |
platelet-derived growth factor receptor, alpha polypeptide |
|
4 |
3 |
PDGFRB |
51 |
platelet-derived growth factor receptor, beta polypeptide |
|
4 |
7 |
PDPK1 |
87 |
3-phosphoinositide dependent protein kinase 1 |
|
4 |
3 |
PEX5 |
58 |
peroxisomal biogenesis factor 5 |
|
4 |
2 |
PIK3CA |
286 |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
|
1 |
1 |
PIK3CB |
36 |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta |
|
22 |
2 |
PIK3R1 |
185 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
|
16 |
13 |
PIN1 |
62 |
peptidylprolyl cis/trans isomerase, NIMA-interacting 1 |
|
9 |
3 |
PLAU |
10 |
plasminogen activator, urokinase |
|
9 |
2 |
PLCG2 |
57 |
phospholipase C, gamma 2 (phosphatidylinositol-specific) |
|
6 |
2 |
PMCH |
242 |
pro-melanin-concentrating hormone |
|
6 |
0 |
PML |
96 |
promyelocytic leukemia |
|
11 |
13 |
POLA1 |
204 |
polymerase (DNA directed), alpha 1, catalytic subunit |
|
9 |
3 |
POLB |
236 |
polymerase (DNA directed), beta |
|
14 |
3 |
POLD1 |
118 |
polymerase (DNA directed), delta 1, catalytic subunit |
|
11 |
3 |
POLG |
72 |
polymerase (DNA directed), gamma |
|
11 |
0 |
PON1 |
142 |
paraoxonase 1 |
|
10 |
1 |
POU1F1 |
4 |
POU class 1 homeobox 1 |
|
20 |
4 |
PPARA |
55 |
peroxisome proliferator-activated receptor alpha |
|
13 |
7 |
PPARG |
263 |
peroxisome proliferator-activated receptor gamma |
|
8 |
2 |
PPARGC1A |
256 |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
15 |
4 |
PPM1D |
246 |
protein phosphatase, Mg2+/Mn2+ dependent, 1D |
|
1 |
0 |
PPP1CA |
227 |
protein phosphatase 1, catalytic subunit, alpha isozyme |
|
3 |
2 |
PRDX1 |
141 |
peroxiredoxin 1 |
|
4 |
0 |
PRKCA |
99 |
protein kinase C, alpha |
|
4 |
13 |
PRKCD |
54 |
protein kinase C, delta |
|
4 |
7 |
PRKDC |
106 |
protein kinase, DNA-activated, catalytic polypeptide |
|
16 |
12 |
PROP1 |
5 |
PROP paired-like homeobox 1 |
|
29 |
2 |
PSEN1 |
224 |
presenilin 1 |
|
18 |
4 |
PTEN |
63 |
phosphatase and tensin homolog |
|
16 |
3 |
PTGS2 |
198 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
11 |
1 |
PTK2 |
166 |
protein tyrosine kinase 2 |
|
5 |
7 |
PTK2B |
165 |
protein tyrosine kinase 2 beta |
|
2 |
7 |
PTPN1 |
33 |
protein tyrosine phosphatase, non-receptor type 1 |
|
5 |
6 |
PTPN11 |
19 |
protein tyrosine phosphatase, non-receptor type 11 |
|
7 |
10 |
PYCR1 |
280 |
pyrroline-5-carboxylate reductase 1 |
|
1 |
0 |
RAD51 |
84 |
RAD51 recombinase |
|
10 |
6 |
RAD52 |
147 |
RAD52 homolog, DNA repair protein |
|
3 |
3 |
RAE1 |
241 |
ribonucleic acid export 1 |
|
2 |
0 |
RB1 |
120 |
retinoblastoma 1 |
|
46 |
21 |
RECQL4 |
128 |
RecQ helicase-like 4 |
|
11 |
0 |
RELA |
143 |
v-rel avian reticuloendotheliosis viral oncogene homolog A |
|
32 |
22 |
RET |
56 |
ret proto-oncogene |
|
4 |
3 |
RGN |
145 |
regucalcin |
|
6 |
0 |
RICTOR |
303 |
RPTOR independent companion of MTOR, complex 2 |
|
0 |
10 |
RPA1 |
67 |
replication protein A1, 70kDa |
|
5 |
6 |
S100B |
70 |
S100 calcium binding protein B |
|
7 |
2 |
SDHC |
182 |
succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa |
|
5 |
0 |
SERPINE1 |
301 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
0 |
1 |
SHC1 |
3 |
SHC (Src homology 2 domain containing) transforming protein 1 |
|
29 |
28 |
SIN3A |
200 |
SIN3 transcription regulator family member A |
|
3 |
6 |
SIRT1 |
150 |
sirtuin 1 |
|
82 |
2 |
SIRT3 |
275 |
sirtuin 3 |
|
4 |
0 |
SIRT6 |
239 |
sirtuin 6 |
|
15 |
0 |
SIRT7 |
269 |
sirtuin 7 |
|
3 |
0 |
SLC13A1 |
270 |
solute carrier family 13 (sodium/sulfate symporter), member 1 |
|
3 |
0 |
SNCG |
140 |
synuclein, gamma (breast cancer-specific protein 1) |
|
5 |
3 |
SOCS2 |
271 |
suppressor of cytokine signaling 2 |
|
7 |
3 |
SOD1 |
130 |
superoxide dismutase 1, soluble |
|
45 |
1 |
SOD2 |
129 |
superoxide dismutase 2, mitochondrial |
|
55 |
0 |
SP1 |
170 |
Sp1 transcription factor |
|
13 |
13 |
SPRTN |
302 |
SprT-like N-terminal domain |
|
0 |
10 |
SQSTM1 |
298 |
sequestosome 1 |
|
0 |
0 |
SST |
53 |
somatostatin |
|
8 |
2 |
SSTR3 |
100 |
somatostatin receptor 3 |
|
2 |
2 |
STAT3 |
22 |
signal transducer and activator of transcription 3 (acute-phase response factor) |
|
13 |
15 |
STAT5A |
23 |
signal transducer and activator of transcription 5A |
|
5 |
13 |
STAT5B |
21 |
signal transducer and activator of transcription 5B |
|
5 |
6 |
STK11 |
93 |
serine/threonine kinase 11 |
|
5 |
2 |
STUB1 |
245 |
STIP1 homology and U-box containing protein 1, E3 ubiquitin protein ligase |
|
1 |
5 |
SUMO1 |
211 |
small ubiquitin-like modifier 1 |
|
6 |
15 |
SUN1 |
277 |
Sad1 and UNC84 domain containing 1 |
|
1 |
0 |
TAF1 |
180 |
TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 250kDa |
|
1 |
9 |
TBP |
194 |
TATA box binding protein |
|
6 |
11 |
TCF3 |
59 |
transcription factor 3 |
|
7 |
2 |
TERC |
7 |
telomerase RNA component |
|
34 |
2 |
TERF1 |
105 |
telomeric repeat binding factor (NIMA-interacting) 1 |
|
9 |
2 |
TERF2 |
116 |
telomeric repeat binding factor 2 |
|
18 |
3 |
TERT |
8 |
telomerase reverse transcriptase |
|
62 |
6 |
TFAP2A |
190 |
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) |
|
7 |
2 |
TFDP1 |
202 |
transcription factor Dp-1 |
|
4 |
4 |
TGFB1 |
91 |
transforming growth factor, beta 1 |
|
25 |
2 |
TNF |
86 |
tumor necrosis factor |
|
20 |
5 |
TOP1 |
83 |
topoisomerase (DNA) I |
|
9 |
5 |
TOP2A |
80 |
topoisomerase (DNA) II alpha |
|
8 |
6 |
TOP2B |
81 |
topoisomerase (DNA) II beta |
|
8 |
4 |
TOP3B |
148 |
topoisomerase (DNA) III beta |
|
7 |
0 |
TP53 |
6 |
tumor protein p53 |
|
139 |
63 |
TP53BP1 |
274 |
tumor protein p53 binding protein 1 |
|
7 |
6 |
TP63 |
234 |
tumor protein p63 |
|
9 |
1 |
TP73 |
281 |
tumor protein p73 |
|
3 |
9 |
TPP2 |
273 |
tripeptidyl peptidase II |
|
2 |
0 |
TRAP1 |
305 |
TNF receptor-associated protein 1 |
|
0 |
5 |
TRPV1 |
306 |
transient receptor potential cation channel, subfamily V, member 1 |
|
0 |
1 |
TXN |
16 |
thioredoxin |
|
15 |
3 |
UBB |
66 |
ubiquitin B |
|
8 |
2 |
UBE2I |
85 |
ubiquitin-conjugating enzyme E2I |
|
5 |
10 |
UCHL1 |
136 |
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) |
|
6 |
1 |
UCP1 |
258 |
uncoupling protein 1 (mitochondrial, proton carrier) |
|
5 |
0 |
UCP2 |
235 |
uncoupling protein 2 (mitochondrial, proton carrier) |
|
22 |
1 |
UCP3 |
232 |
uncoupling protein 3 (mitochondrial, proton carrier) |
|
22 |
1 |
VCP |
71 |
valosin containing protein |
|
3 |
5 |
VEGFA |
77 |
vascular endothelial growth factor A |
|
15 |
2 |
WRN |
13 |
Werner syndrome, RecQ helicase-like |
|
88 |
20 |
XPA |
126 |
xeroderma pigmentosum, complementation group A |
|
15 |
3 |
XRCC5 |
112 |
X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining) |
|
24 |
6 |
XRCC6 |
117 |
X-ray repair complementing defective repair in Chinese hamster cells 6 |
|
19 |
12 |
YWHAZ |
164 |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta |
|
3 |
13 |
ZMPSTE24 |
233 |
zinc metallopeptidase STE24 |
|
13 |
0 |
Leave a Reply